PPARG and familial pancreatic carcinoma: Co-treatment of GW9662 inhibited the induction of caveolin-1 and p27 by CDIM9 in MDA-MB231 cells (Figure 2a), suggesting that these responses were PPAR-γ dependent, as previously described in colon and pancreatic cancer cells [26,28-30].